Interaction between various resistance modifiers and apoptosis inducer 12H-benzo[a]phenothiazine

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2833-2836

  Mucsi, Ilona ^e   Varga, Andreas ^a   Kawase, Masami ^b   Motohashi, Noboru ^c   Molnar, Joseph ^d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b JOSAI UNIVERSITY   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF SZEGED   (Hungary)

^e NONE

Author keywords

12H benzo phenothiazine; Apoptosis induction; Mouse T cell lymphoma cells; Resistance modifiers; Trifluoroketones

Indexed keywords

1,1,1 TRIFLUORO 3 [2 (4,5 DIMETHYLOXAZOLYL)] 2 PROPANONE; 12H BENZO[A]PHENOTHIAZINE; 3 (2 BENZOXAZOLYL) 1,1,1 TRIFLUORO 2 PROPHANONE; APOPTOSIS INDUCING FACTOR; M 627; OMEPRAZOLE; PROMETHAZINE; TF 14; TF 29; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; GENETIC TRANSFORMATION; LYMPHOMA CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STAINING;

ANIMALS; APOPTOSIS; CALMODULIN; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HYDROCARBONS, FLUORINATED; LYMPHOMA, T-CELL; MICE; OMEPRAZOLE; OXAZOLES; PHENOTHIAZINES; PROMETHAZINE; PROTON PUMPS; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0036765396     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Kawase M, Sakagami H, Kusama K, Motohashi N and Saito S: α-Trifluoromethylated acyloins induce apoptosis in human oral tumor cell lines. Bioorg Med Chem Lett 9: 3113-3118, 1999.
2. Motohashi N, Kurihara T, Satoh K, Sakagami H, Mucsi I, Pusztai R, Szabo M and Molnar J: Antitumor activity of benzo[α]phenothiazines. Anticancer Res 19: 1837-1842, 1999.
3. Molnar J, Szabo D, Mandi Y, Mucsi I, Fischer J, Varga A, König S and Motohashi N: Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds. Anticancer Res 18: 3033-3038, 1998.
4. Molnar J, Hevér A, Fakla I, Fischer J, Ocsovszki I and Asztalos A: Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistance tumor cells. Anticancer Res 17: 481-486, 1997.
5. Motohashi N, Kawase M, Kurihara T, Hevér A, Nagy Zs, Ocsovszki I, Tanaka M and Molnar J: Synthesis and antitumor activity of 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkylureas as potential anticancer agents. Anticancer Res 16: 2525-2532, 1996.
6. Motohashi N, Sakagami H, Kamata K and Yamamoto Y: Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[α] phenothiazine derivates. Anticancer Res 11: 1933-1938, 1991.
7. Kawase M, Teshima M, Saito S and Tani S: Trifluoroacetylation of methylpyridines and other methylazines: a convenient access to trifluoroacetonylazines. Heterocycles 48: 2103-2109, 1998.
8. Cornwell MM, Pastan I and Gottesman MM: Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166-2170, 1987.
9. Koopmann G, Rentelinger CP, Kuijten Ga, Koehnen RM, Pals ST and Van Oers MH: Annexin V flow cytometric detection of phosphatidyl-serine expression on B cells undergoing apoptosis. Blood 84: 1115-1120, 1994.